|
118.
|
|
7 p, 264.1 KB |
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
/
Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ;
Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ;
Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ;
Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ;
Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ;
Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ;
Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ;
Szmit, S. (Institute of Hematology and Transfusion Medicine) ;
Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ;
Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ;
Jurczak, W. (MSC National Research Institute of Oncology) ;
Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ;
Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ;
Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ;
Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ;
Parrini, I. (Department of Cardiology. Mauriziano Hospital) ;
Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ;
Pudil, R. (University Hospital Hradec Králové. Sokolská) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ;
Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ;
Farmakis, D. (University of Cyprus Medical School) ;
Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ;
Stephens, R. (Patient Advocate) ;
Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ;
Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 -  10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7
|
|
|
119.
|
|
12 p, 1.1 MB |
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
/
Lara, Pedro C. (Centro Oncológico Integral de Canarias. Hospital Universitario San Roque. Universidad Fernando Pessoa Canarias) ;
Rodríguez-Melcón, Juan I. (Hospital Universitario de Gran Canaria Doctor Negrín. Oncología Radioterápica) ;
Palacios-Eito, Amalia (Hospital Universitario "Reina Sofía" (Còrdova). Instituto Maimónides de Investigación Biomédica de Córdoba. Oncología Radioterápica) ;
Lozano, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Hervás-Morón, Asunción (Hospital Ramón y Cajal. Oncología Radioterápica) ;
Villafranca, Elena (Hospital Universitario de Navarra. Oncología Radioterápica) ;
Gómez-Iturriaga, Alfonso (Hospital Universitario Cruces. BioCruces. Oncología Radioterápica) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Maldonado, Xavier (Vall d'Hebron Institut d'Oncologia)
Background: Intermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight gain, loss of libido, and hot flashes. [...]
2022 - 10.3389/fonc.2022.891886
Frontiers in Oncology, Vol. 12 (July 2022) , p. 891886
|
|
|
120.
|
|
19 p, 630.3 KB |
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours
/
López, Fernando (Instituto Universitario de Oncología del Principado de Asturias) ;
Shah, Jatin P. (Sechenov University) ;
Beitler, Jonathan J. (Maine General Hospital) ;
Snyderman, Carl H. (University of Pittsburgh School of Medicine) ;
Lund, Valerie (The Royal National Throat Nose and Ear Hospital. UCLH Foundation Trust) ;
Piazza, Cesare (University of Brescia (Itàlia)) ;
Mäkitie, Antti A. (Helsinki University Hospital) ;
Guntinas-Lichius, Orlando (Jena University Hospital (Alemanya)) ;
Rodrigo, Juan P. (Instituto Universitario de Oncología del Principado de Asturias) ;
Kowalski, Luiz P. (University of São Paulo Medical School. Department of Head and Neck Surgery) ;
Quer, Miquel (Institut d'Investigació Biomèdica Sant Pau) ;
Shaha, Ashok (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ;
Homma, Akihiro (Hokkaido University. Graduate School of Medicine) ;
Sanabria, Alvaro (CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello) ;
Ferrarotto, Renata (The University of Texas MD Anderson Cancer Center) ;
Lee, Anne W.M. (The University of Hong Kong-Shenzhen Hospital. Clinical Oncology Center) ;
Lee, Victor H.F. (The University of Hong Kong-Shenzhen Hospital. Clinical Oncology Center) ;
Rinaldo, Alessandra (University of Udine School of Medicine) ;
Ferlito, Alfio (International Head and Neck Scientific Group)
Endoscopic endonasal surgery has been demonstrated to be effective in the treatment of selected cases of sinonasal cancers. However, in cases of locally advanced neoplasms, as well as recurrences, the most appropriate approach is still debated. [...]
2022 - 10.1007/s12325-022-02080-x
Advances in Therapy, Vol. 39 Núm. 6 (june 2022) , p. 2379-2397
|
|
|
121.
|
|
9 p, 203.7 KB |
Outcomes of men with HIV and germ cell cancer : Results from an international collaborative study
/
Hentrich, Marcus Ulrich (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ;
Bower, Mark (National Centre for HIV Malignancy. Chelsea and Westminster Hospital) ;
Daugaard, Gedske (Department of Oncology. University Hospital Copenhagen. Rigshospitalet) ;
Dieing, Annette (Department of Hematology and Oncology. Vivantes Klinikum am Urban) ;
Bickel, Markus (Infektiologikum) ;
Berretta, Massimiliano (Department of Clinical and Experimental Medicine. University of Messina) ;
Lesmeister, Florian (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ;
Jurinovic, Vindi (Institute of Biometrics and Epidemiology. Ludwig Maximilian University of Munich) ;
Stoehr, Albrecht (Institute for Interdisciplinary Medicine) ;
Heinzelbecker, Julia (Department of Urology and Pediatric Urology. Saarland University Medical Center and Saarland University) ;
Krznaric, Ivanka (Practice of Infectious Diseases) ;
Dieckmann, Klaus-Peter (Department of Urology. Asklepios Klinik Altona) ;
Necchi, Andrea (IRCCS San Raffaele Hospital and Scientific Institute. Vita-Salute San Raffaele University) ;
Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Rockstroh, Jürgen Kurt (Department of Medicine I. University Hospital Bonn) ;
Brito, Margarida (Instituto Português de Oncologia Francisco Gentil) ;
Pfister, David (Department of Urology. University Hospital Cologne) ;
Hoffmann, Christian (University Hospital of Schleswig Holstein)
Background: Previous studies have shown that men with HIV and germ cell cancer (HIV-GCC) have inferior overall survival (OS) in comparison with their HIV-negative counterparts. However, little information is available on treatments and outcomes of HIV-GCC in the era of combination antiretroviral therapy (cART). [...]
2022 - 10.1002/cncr.33928
Cancer, Vol. 128 Núm. 2 (January 2022) , p. 260-268
|
|
|
122.
|
|
19 p, 1.1 MB |
Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer : Systematic Review on the Performance of Risk Stratification Models
/
Guerrero-Ramos, F. (Hospital Universitario 12 de Octubre (Madrid). Servicio de Urología) ;
Subiela, J.D. (Hospital Ramón y Cajal. Servicio de Urología. Instituto Ramón y Cajal de Investigación Sanitaria. Universidad De Alcalá) ;
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ;
Aumatell, Julia (Fundació Puigvert. Servicio de Urología) ;
Manfredi, Celeste (Unit Of Urology. Department Of Woman. Child And General And Specialized Surgery. University Of Campania 'Luigi Vanvitelli') ;
Bozzini, Giorgia (Department Of Urology. Asst Lariana Ospedale Sant'Anna) ;
Romero-Otero, Javier (Department Of Urology. Hospital Universitario Hm Sanchinarro) ;
Couñago, Felipe (Hospital La Milagrosa)
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cancer (NMIBC) in risk groups according to the probability of recurrence and progression. OBJECTIVE: To systematically review the current evidence regarding risk stratification of NMIBC. [...]
2022 - 10.3233/BLC-220055
Bladder Cancer, Vol. 8 Núm. 4 (2022) , p. 339-357
|
|
|
123.
|
|
8 p, 1.3 MB |
Incidence and Prognosis of Colorectal Cancer After Heart Transplantation : Data From the Spanish Post-Heart Transplant Tumor Registry
/
Sagastagoitia-Fornie, Marta (Ferrol University Hospital Complex) ;
Morán-Fernández, Laura (University Hospital October 12) ;
Blázquez-Bermejo, Zorba (Gregorio Marañón Hospital) ;
Díaz-Molina, Beatriz (Central University Hospital of Asturias) ;
Gómez-Bueno, Manuel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Almenar Bonet, Luis (La Fe Hospital) ;
López-Granados, Amador (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
González-Vílchez, Francisco (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Mirabet Pérez, Sonia (Institut d'Investigació Biomèdica Sant Pau) ;
Garcia-Romero, Elena (Hospital Universitari de Bellvitge) ;
Jose M., Sobrino-Márquez (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Rábago Juan-Aracil, Gregorio (Clínica Universidad de Navarra) ;
Castel, María (Hospital Clínic i Provincial de Barcelona) ;
Blasco-Peiro, Teresa (Hospital Universitario Miguel Servet (Saragossa)) ;
Garrido Bravo, Iris (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
de la Fuente-Galán, Luis (Hospital Clínico Universitario de Valladolid) ;
Muñiz, Javier (Universidade da Coruña) ;
Crespo-Leiro, Maria Generosa (Complejo Hospitalario Universitario de A Coruña) ;
Universitat Autònoma de Barcelona
In this observational and multicenter study, that included all patients who underwent a heart transplantation (HT) in Spain from 1984 to 2018, we analyzed the incidence, management, and prognosis of colorectal cancer (CRC) after HT. [...]
2023 - 10.3389/ti.2023.11042
Transplant International, Vol. 36 (may 2023)
|
|
|
124.
|
|
11 p, 959.0 KB |
Outcome of liver cancer patients with SARS-CoV-2 infection : An International, Multicentre, Cohort Study
/
Muñoz-Martínez, S (Hospital Clínic i Provincial de Barcelona) ;
Sapena, Victor (Hospital Clínic i Provincial de Barcelona) ;
Forner, Alejandro (Hospital Clínic i Provincial de Barcelona) ;
Bruix, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Sanduzzi Zamparelli, Marco (Hospital Clínic i Provincial de Barcelona) ;
Ríos, José (Hospital Clínic i Provincial de Barcelona) ;
Bouattour, Mohamed (Hôpital Beaujon) ;
El-Kassas, Mohamed (Helwan University) ;
Leal, Cassia R. G. (Hospital Federal do Servidores do Estado) ;
Mocan, Tudor ("Octavian Fodor" Institute for Gastroenterology and Hepatology) ;
Nault, Jean-Charles (Université de Paris) ;
Alves, Rogerio C. P. (Bp Beneficência Portuguesa de São Paulo) ;
Reeves, Helen L. (Newcastle University Translational and Clinical Research Institute) ;
Da Fonseca, Leonardo G (University of Sao Paulo School of Medicine) ;
García-Juárez, Ignacio (National Institute of Medical Sciences and Nutrition Salvador Zubirán) ;
Pinato, David J. (Imperial College London) ;
Varela Calvo, Maria (Hospital Universitario Central de Asturias) ;
Alqahtani, Saleh A. (King Faisal Specialist Hospital & Research Center) ;
Alvares-da-Silva, Mario R. (Universidade Federal do Rio Grande do Sul) ;
Bandi, Juan C. (Hospital Italiano) ;
Rimassa, Lorenza (Humanitas Cancer Center) ;
Lozano, Mar (Hospital Universitario Infanta Leonor) ;
González Santiago, Jesús M. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Tacke, Frank (Campus Virchow-Klinikum and Campus Charité Mitte) ;
Sala, Margarita (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Anders, María (Hepatología) ;
Lachenmayer, Anja (Bern University Hospital) ;
Piñero, Federico (Hospital Universitario Austral) ;
França, Alex (Federal University of Sergipe) ;
Guarino, Maria (University of Naples Federico II) ;
Elvevi, Alessandra (Bicocca School of Medicine) ;
Cabibbo, Giuseppe (University of Palermo) ;
Peck-Radosavljevic, Markus (Klinikum Klagenfurt am Wörthersee) ;
Rojas, Ángela (Universidad de Sevilla) ;
Vergara, Mercedes (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Braconi, Chiara (University of Glasgow) ;
Pascual, Sonia (HGU Dr. Balmis) ;
Perelló, Christie (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Mello, Vivianne (AMO CLINIC) ;
Rodríguez-Lope, Carlos (IDIVAL) ;
Acevedo, Juan (University Hospitals Plymouth NHS Trust (Regne Unit)) ;
Villani, Rosanna (Department of Medical and Surgical Sciences) ;
Hollande, Clemence (Hôpital Beaujon) ;
Vilgrain, Valérie (Hôpital Beaujon) ;
Tawheed, Ahmed (Helwan University) ;
Ferguson Theodoro, Carmem (Universidade Federal Fluminense) ;
Sparchez, Zeno (University of Medicine and Pharmacy) ;
Blaise, Lorraine (Université de Paris) ;
Viera-Alves, Daniele E. (Bp Beneficência Portuguesa de São Paulo) ;
Watson, Robyn (Newcastle University Translational and Clinical Research Institute) ;
Carrilho, Flair J. (University of Sao Paulo School of Medicine) ;
Moctezuma-Velázquez, Carlos (National Institute of Medical Sciences and Nutrition Salvador Zubirán) ;
D'Alessio, Antonio (Humanitas University) ;
Iavarone, Massimo (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Reig, María (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population. [...]
2022 - 10.1111/liv.15320
Liver International, Vol. 42 (june 2022) , p. 1891-1901
|
|
|
125.
|
|
12 p, 295.7 KB |
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer : Differences between Patients with Hematological Malignancies and Solid Tumors
/
Royo-Cebrecos, Cristina (Hospital Nostra Senyora de Meritxell (Principat d'Andorra)) ;
Laporte-Amargós, Júlia (Hospital Universitari de Bellvitge) ;
Peña, Marta (Hospital Universitari de Bellvitge) ;
Ruiz-Camps, Isabel (Hospital Universitari Vall d'Hebron) ;
Puerta-Alcalde, Pedro (Hospital Clínic i Provincial de Barcelona) ;
Abdala, Edson (Univesity of São Paulo) ;
Oltolini, Chiara (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Akova, Murat (Hacettepe University School of Medicine) ;
Montejo, Miguel (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Mikulska, Malgorzata (University of Genoa (DISSAL) and Ospedale Policlinico San Martino) ;
Martín-Dávila, Pilar (Hospital Universitario Ramón y Cajal (Madrid)) ;
Herrera, Fabian (Centro de Educación Médica e Investigaciones Clínicas) ;
Gasch Blasi, Oriol (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Drgona, Lubos (Comenius University and National Cancer Institute) ;
Morales, Hugo Manuel Paz (Hospital Erasto Gaertner) ;
Brunel, Anne-Sophie (Lausanne University Hospital) ;
García, Estefanía (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Isler, Burcu (Istanbul Education and Research Hospital) ;
Kern, Winfried V. (University of Freiburg Medical Center and Faculty of Medicine) ;
Palacios-Baena, Zaira R. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
de la Calle, Guillermo Maestro (Instituto de Investigación Hospital "12 de Octubre" (i+12)) ;
Montero, María Milagro (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Kanj, Souha S. (American University of Beirut Medical Center) ;
Sipahi, Oguz R. (Ege University) ;
Calik, Sebnem (University of Health Science Izmir Bozyaka Training and Research Hospital) ;
Márquez-Gómez, Ignacio (Hospital Regional Universitario de Málaga) ;
Marin, Jorge I. (Clínica Maraya) ;
Gomes, Marisa Z. R. (Hospital Federal dos Servidores do Estado) ;
Hemmatti, Philipp (Charité University Medical School) ;
Araos, Rafael (Instituto de Ciencias e Innovación en Medicina) ;
Peghin, Maddalena (University of Udine and Azienda Sanitaria Universitaria Integrata in Udine) ;
Del Pozo, Jose Luis (Clínica Universitaria Navarra) ;
Yáñez, Lucrecia (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Tilley, Robert (University Hospitals Plymouth NHS Trust (Regne Unit)) ;
Manzur, Adriana (Hospital Rawson) ;
Novo, Andrés (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Carratalà, Jordi (Hospital Universitari de Bellvitge) ;
Gudiol, Carlota (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona
To assess the clinical features and outcomes of Pseudomonas aeruginosa bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies (HM) and with solid tumors (ST), and identify the risk factors for 30-day mortality. [...]
2022 - 10.3390/pathogens11101132
Pathogens, Vol. 11 (september 2022)
|
|
|
126.
|
|
10 p, 1.4 MB |
Experimental study of the quantification of indocyanine green fluorescence in ischemic and non-ischemic anastomoses, using the SERGREEN software program
/
Serra-Aracil, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
García-Nalda, Albert (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Serra-Gómez, Borja (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Serra-Gómez, Álvaro (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Mora-López, Laura (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Pallisera-Lloveras, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Lucas-Guerrero, Victoria (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Navarro-Soto, Salvador (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Universitat Autònoma de Barcelona
Tissue ischemia is a key risk factor in anastomotic leak (AL). Indocyanine green (ICG) is widely used in colorectal surgery to define the segments with the best vascularization. In an experimental model, we present a new system for quantifying ICG fluorescence intensity, the SERGREEN software. [...]
2022 - 10.1038/s41598-022-17395-6
Scientific reports, Vol. 12 (july 2022)
|
|
|
127.
|
|
17 p, 911.8 KB |
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting
/
Romeo, Margarita (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gil-Martín, Marta (Hospital Universitari de Bellvitge) ;
Gaba, Lydia (Hospital Clínic i Provincial de Barcelona) ;
Teruel, Iris (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Taus, Álvaro (Hospital del Mar (Barcelona, Catalunya)) ;
Fina, Claudia (Institut Català d'Oncologia) ;
Masvidal, Maria (Hospital Universitari de Reus) ;
Murata, Paola (Hospital Universitari Arnau de Vilanova) ;
Fernández-Plana, Julen (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Martínez Bueno, Alejandro (Hospital Quirón Dexeux) ;
Pérez, Cristina (Xarxa Sanitària i Social Santa Tecla) ;
García García, Yolanda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Rodriguez, Valerie (Hospital de Tortosa Verge de la Cinta) ;
Cros Costa, Sara (Hospital General de Granollers) ;
Parera, Marta (Hospital Universitari de Vic) ;
Zanui, Montserrat (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Catot, Silvia (Xarxa Assistencial Universitària de Manresa) ;
Pardo, Beatriz (Hospital Universitari de Bellvitge) ;
Plaja, Andrea (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Esteve, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Barretina-Ginesta, Maria-Pilar (Institut Català d'Oncologia)
Since the irruption of PARPi in the therapeutic armamentarium for ovarian cancer, concerns regarding post-progression treatment outcomes have emerged, owing to known crossed-resistance mechanisms between PARPi and platinum. [...]
2022 - 10.3390/cancers14184414
Cancers, Vol. 14 (september 2022)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
